Andrea Mattevi

Pavia, 27100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 133 publications

Evolution of human IL4I1 preference for aromatic amino acids from a broad-specificity L-amino acid oxidase ancestor.

Evolution of human IL4I1 preference for aromatic amino acids from a broad-specificity L-amino acid oxidase ancestor.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 12, 2026

COQ8 chaperones coenzyme Q lipid intermediates through ATP-driven structural gating.

COQ8 chaperones coenzyme Q lipid intermediates through ATP-driven structural gating.

Journal: Science advances

Published: July 29, 2026

Development of a first-in-class homolog-selective, covalent NOX4 inhibitor.

Development of a first-in-class homolog-selective, covalent NOX4 inhibitor.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 10, 2026

AI-Enhanced Adaptive Virtual Screening Platform Enabling Exploration of 69 Billion Molecules Discovers Structurally Validated FSP1 Inhibitors.

AI-Enhanced Adaptive Virtual Screening Platform Enabling Exploration of 69 Billion Molecules Discovers Structurally Validated FSP1 Inhibitors.

Journal: bioRxiv : the preprint server for biology

Published: April 03, 2026

A synergistic interaction between PRMT5 and LSD1 inhibitors in AML.

A synergistic interaction between PRMT5 and LSD1 inhibitors in AML.

Journal: Science advances

Published: March 27, 2026

The glycine-arginine-rich motif of 53BP1 modulates RNA interactions necessary for its liquid-liquid phase separation during DNA Damage Response.

The glycine-arginine-rich motif of 53BP1 modulates RNA interactions necessary for its liquid-liquid phase separation during DNA Damage Response.

Journal: bioRxiv : the preprint server for biology

Published: February 09, 2026

Myeloperoxidase: one enzyme, two jobs.

Myeloperoxidase: one enzyme, two jobs.

Journal: Cell research

Published: November 11, 2025

Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors.

Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors.

Journal: ACS chemical neuroscience

Published: August 12, 2025

Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of Schistosoma mansoni.

Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of Schistosoma mansoni.

Journal: ACS infectious diseases

Published: July 02, 2025

Enhancing Selectivity and Potency of SNAr Covalent Inhibitors of NADPH Oxidase Enzymes.

Enhancing Selectivity and Potency of SNAr Covalent Inhibitors of NADPH Oxidase Enzymes.

Journal: Journal of medicinal chemistry

Published: June 20, 2025

Complete Enzyme Clustering Enhances Coenzyme Q Biosynthesis via Substrate Channeling.

Complete Enzyme Clustering Enhances Coenzyme Q Biosynthesis via Substrate Channeling.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2025

Complete enzyme clustering enhances coenzyme Q biosynthesis via substrate channeling.

Complete enzyme clustering enhances coenzyme Q biosynthesis via substrate channeling.

Journal: Nature communications

Published: May 29, 2025

Showing 1-12 of 133

Last Updated: 09/26/2026